MarketWatch · Bloomberg
Moderna’s stock tumbles after reported leak of data for cancer vaccine
Thursday, October 22, 2026
Moderna and Merck shares fell after data on their personalized melanoma vaccine became public before its scheduled presentation. The companies were expected to present Phase 3 data for the experimental cancer vaccine at a medical conference. Bloomberg reported that investors determined the data was insufficient to demonstrate a new era of cancer treatments.
Reported by 2 outlets:
